A microRNA component of the p53 tumour suppressor network

被引:2160
作者
He, Lin
He, Xingyue
Lim, Lee P.
De Stanchina, Elisa
Xuan, Zhenyu
Liang, Yu
Xue, Wen
Zender, Lars
Magnus, Jill
Ridzon, Dana
Jackson, Aimee L.
Linsley, Peter S.
Chen, Caifu
Lowe, Scott W.
Cleary, Michele A.
Hannon, Gregory J.
机构
[1] Rosetta Inpharmat, Seattle, WA 98109 USA
[2] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA
[3] SUNY Stony Brook, Genet Program, Stony Brook, NY 11794 USA
[4] Appl Biosyst Inc, Adv Res & Technol, Foster City, CA 94404 USA
关键词
D O I
10.1038/nature05939
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A global decrease in microRNA (miRNA) levels is often observed in human cancers(1,2), indicating that small RNAs may have an intrinsic function in tumour suppression. To identify miRNA components of tumour suppressor pathways, we compared miRNA expression profiles of wild-type and p53-deficient cells. Here we describe a family of miRNAs, miR-34a-c, whose expression reflected p53 status. Genes encoding miRNAs in the miR-34 family are direct transcriptional targets of p53, whose induction by DNA damage and oncogenic stress depends on p53 both in vitro and in vivo. Ectopic expression of miR-34 induces cell cycle arrest in both primary and tumour-derived cell lines, which is consistent with the observed ability of miR-34 to downregulate a programme of genes promoting cell cycle progression. The p53 network suppresses tumour formation through the coordinated activation of multiple transcriptional targets, and miR-34 may act in concert with other effectors to inhibit inappropriate cell proliferation.
引用
收藏
页码:1130 / U16
页数:6
相关论文
共 29 条
  • [1] CHD5 is a tumor suppressor at human 1p36
    Bagchi, Anindya
    Papazoglu, Cristian
    Wu, Ying
    Capurso, Daniel
    Brodt, Michael
    Francis, Dailia
    Bredel, Markus
    Vogel, Hannes
    Mills, Alea A.
    [J]. CELL, 2007, 128 (03) : 459 - 475
  • [2] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004)
    Bartel, David P.
    [J]. CELL, 2007, 131 (04) : 11 - 29
  • [3] RADIATION-INDUCED CELL-CYCLE ARREST COMPROMISED BY P21 DEFICIENCY
    BRUGAROLAS, J
    CHANDRASEKARAN, C
    GORDON, JI
    BEACH, D
    JACKS, T
    HANNON, GJ
    [J]. NATURE, 1995, 377 (6549) : 552 - 557
  • [4] A system for stable expression of short interfering RNAs in mammalian cells
    Brummelkamp, TR
    Bernards, R
    Agami, R
    [J]. SCIENCE, 2002, 296 (5567) : 550 - 553
  • [5] MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias
    Calin, GA
    Liu, CG
    Sevignani, C
    Ferracin, M
    Felli, N
    Dumitru, CD
    Shimizu, M
    Cimmino, A
    Zupo, S
    Dono, M
    Dell'Aquila, ML
    Alder, H
    Rassenti, L
    Kipps, TJ
    Bullrich, F
    Negrini, M
    Croce, CM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (32) : 11755 - 11760
  • [6] Real-time quantification of microRNAs by stem-loop RT-PCR
    Chen, CF
    Ridzon, DA
    Broomer, AJ
    Zhou, ZH
    Lee, DH
    Nguyen, JT
    Barbisin, M
    Xu, NL
    Mahuvakar, VR
    Andersen, MR
    Lao, KQ
    Livak, KJ
    Guegler, KJ
    [J]. NUCLEIC ACIDS RESEARCH, 2005, 33 (20) : e179.1 - e179.9
  • [7] MICE LACKING P21(C/P1/WAF1) UNDERGO NORMAL DEVELOPMENT, BUT ARE DEFECTIVE IN G1 CHECKPOINT CONTROL
    DENG, CX
    ZHANG, PM
    HARPER, JW
    ELLEDGE, SJ
    LEDER, P
    [J]. CELL, 1995, 82 (04) : 675 - 684
  • [8] Probing tumor phenotypes using stable and regulated synthetic microRNA precursors
    Dickins, RA
    Hemann, MT
    Zilfou, JT
    Simpson, DR
    Ibarra, I
    Hannon, GJ
    Lowe, SW
    [J]. NATURE GENETICS, 2005, 37 (11) : 1289 - 1295
  • [9] P53 and radiation responses
    Fei, PW
    El-Deiry, WS
    [J]. ONCOGENE, 2003, 22 (37) : 5774 - 5783
  • [10] The complexity of p53 modulation: emerging patterns from divergent signals
    Giaccia, AJ
    Kastan, MB
    [J]. GENES & DEVELOPMENT, 1998, 12 (19) : 2973 - 2983